An early experience with Simulect (basiliximab): an IL-2 receptor antibody
- 1 November 2000
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 32 (7) , 1739-1740
- https://doi.org/10.1016/s0041-1345(00)01394-4
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipientsThe Lancet, 1997
- EARLY VERSUS LATE ACUTE RENAL ALLOGRAFT REJECTIONTransplantation, 1993
- LRISK FACTORS FOR CHRONIC REJECTION IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993